J
Jennifer Nielsen Kahn
Researcher at Merck & Co.
Publications - 24
Citations - 653
Jennifer Nielsen Kahn is an academic researcher from Merck & Co.. The author has contributed to research in topics: Candida albicans & Glucan. The author has an hindex of 13, co-authored 24 publications receiving 584 citations.
Papers
More filters
Journal ArticleDOI
Acquired Echinocandin Resistance in a Candida krusei Isolate Due to Modification of Glucan Synthase
Jennifer Nielsen Kahn,Guillermo Garcia-Effron,Ming Jo Hsu,Steven Park,Kieren A. Marr,David S. Perlin +5 more
TL;DR: A Candida krusei strain from a patient with acute myelogenous leukemia that displayed reduced susceptibility to echinocandin drugs contained a heterozygous mutation, T2080K, in FKS1, which altered the sensitivity of glucan synthase to Echinocander drugs, consistent with a common mechanism for echinOCandin resistance in Candida spp.
Journal ArticleDOI
PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural Products
Bo Jiang,Deming Xu,John J. Allocco,Craig A. Parish,John Davison,Karynn Veillette,Susan Sillaots,Wenqi Hu,Roberto Rodriguez-Suarez,Steve Trosok,Li Zhang,Yang Li,Fariba Rahkhoodaee,Tara Ransom,Nick Martel,Hao Wang,Daniel Gauvin,Judyann Wiltsie,Douglas Wisniewski,Scott P. Salowe,Jennifer Nielsen Kahn,Ming Jo Hsu,Robert A. Giacobbe,George K. Abruzzo,Amy M. Flattery,Charles Gill,Phil Youngman,Kenneth E. Wilson,Gerald F. Bills,Gonzalo Platas,Fernando Pelaez,Maria Teresa Diez,Sarah Kauffman,Jeff Becker,Guy H. Harris,Paul A. Liberator,Terry Roemer +36 more
TL;DR: Parnafungin displays potent and broad spectrum activity against diverse, clinically relevant fungal pathogens and reduces fungal burden in a murine model of disseminated candidiasis, and mechanism-of-action determination of crude fermentation extracts by chemical-genetic profiling brings a powerful strategy to natural-product-based drug discovery.
Journal ArticleDOI
Caspofungin Susceptibility in Aspergillus and Non-Aspergillus Molds: Inhibition of Glucan Synthase and Reduction of β-d-1,3 Glucan Levels in Culture
TL;DR: It is demonstrated that caspofungin inhibits β-d-1,3 glucan synthesis and reduces in vitro growth of clinical isolates from the genera Alternaria, Curvularia, Scedosporium, Acremonium, Bipolaris, and Trichoderma.
Journal ArticleDOI
Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis
Paul A. Mann,Catherine A. McLellan,Sandra Koseoglu,Qian Si,Elena Kuzmin,Amy M. Flattery,Guy H. Harris,Xinwei Sher,Nicholas J. Murgolo,Hao Wang,Kristine Devito,Nuria de Pedro,Olga Genilloud,Jennifer Nielsen Kahn,Bo Jiang,Michael Costanzo,Charles Boone,Charles G. Garlisi,Susan Lindquist,Terry Roemer +19 more
TL;DR: The results establish Mcd4 as a promising antifungal target and confirm the GPI cell wall anchor synthesis pathway as aPromising antif fungus target area by demonstrating that effects of inhibiting it are more general than previously recognized.
Journal ArticleDOI
Distribution of the antifungal agents sordarins across filamentous fungi
Francisca Vicente,Angela Basilio,Gonzalo Platas,Javier Collado,Gerald F. Bills,Antonio González del Val,Jesús Martín,José R. Tormo,Guy H. Harris,Deborah L. Zink,Michael C. Justice,Jennifer Nielsen Kahn,Fernando Pelaez +12 more
TL;DR: The production of sordarin is a trait more frequently associated to members of the Xylariales than to any other fungal order, and it was found that sordarins were the most frequently found compounds in the class.